Viewing Study NCT04317651


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2026-01-02 @ 5:20 PM
Study NCT ID: NCT04317651
Status: UNKNOWN
Last Update Posted: 2020-03-25
First Post: 2020-03-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Crizotinib in ALK Rearranged Non-small-cell Lung Cancer
Sponsor: Fondazione Ricerca Traslazionale
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module